Journal
/
면역학 및 감염병학
/
קביעת פעילות ציטוטוקסית אופטימלית של CD8 תאי T ספציפי אדם Her2neu על ידי השוואת Assay שחרור Cr51 למערכת xCELLigence
JoVE 신문
면역학 및 감염병학
This content is Free Access.
JoVE 신문 면역학 및 감염병학
Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System
Please note that all translations are automatically generated. Click here for the English version.

קביעת פעילות ציטוטוקסית אופטימלית של CD8 תאי T ספציפי אדם Her2neu על ידי השוואת Assay שחרור Cr51 למערכת xCELLigence

24,592 Views

•

11:31 min

•

August 08, 2012

DOI:

10.3791/3683-v

DOI:
10.3791/3683-v

•

11:31 min
August 08, 2012

•

5 Views
, ,
1Department of Immunology,College of Medicine, Mayo Clinic

Tags

Cytotoxic ActivityCD8 T CellsCr51 Release AssayXCELLigence SystemT Cell Receptor (TCR)Antigen-specific CD8 T CellsELIspotFlow CytometryCytotoxicity AssayChromium Release Assay (CRA)Gamma RadiationReproducibilityCaspase ReleaseBLT Esterase ActivityCD107 ExpressionImpedance-based AssayRoche XCelligence System

Read Article

Cite this Article

Erskine, C. L., Henle, A. M., Knutson, K. L. Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System. J. Vis. Exp. (66), e3683, doi:10.3791/3683 (2012).

Download .ris file

Copy

Share Video

.

Copy